Quick Take: AstraZeneca Pursues Traditional Chinese Medicine As New Source For R&D
This article was originally published in PharmAsia News
Executive Summary
AstraZeneca signs research collaboration with Shanghai’s Fudan University to investigate mechanism of action for a TCM compound to treat cardiovascular disease.